Lapatinib Tablet
Product Images NDC 68180-801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lapatinib (NDC 68180-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 4

FDA Label Image

Lapatinib Chemical Structure (Lapatinib Fig1)

FDA Label Image

Lapatinib Study Graph (Lapatinib Fig2)

FDA Label Image

Lapatinib Study Graph (Lapatinib Fig3)

FDA Label Image

Lapatinib Study Graph (Lapatinib Fig4)

FDA Label Image

Lapatinib Tablets Label (Lapatinib Label)

Lapatinib Tablets Label (Lapatinib Label)
This is a description of a medication called Lapatinib, which comes in coated tablets containing 398mg of Lapatinib Ditosylate, equivalent to 10250mg of Lapatinib. The usual dosage should be determined by a prescribing physician. Safety closures should be used when dispensing the product. The medication should be stored at 25°C with excursions permitted between 10-15°C to 10-30°C. The tablets are manufactured by Natco Pharma Limited in India and distributed by Lupin Pharmaceuticals in the United States. The rest of the information appears to be batch and lot numbers, as well as manufacturing revision dates.*
FDA Label Image

Lapatinib Vizag Label

Lapatinib Vizag Label
This is a medication package of Lapatinib tablets, with each film-coated table containing a prescribed dose of the medication. The manufacturer is Natco Pharma Limited, located in Visakhapainam, India. The product's National Drug Code number is 68180-801-36. The package comes with accompanying information with dosage and safety information. The medication is produced by Lupin Pharmaceuticals, Inc. in the United States. The tablets must be stored at a temperature between 25°C (77°F) and 30°C (86°F). The package is prescription only, and there is a unique ID number for it.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.